The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis

(2020) Niranjan J. Sathianathen et al.   EUROPEAN UROLOGY

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2

(2019) Baris Turkbey et al.   EUROPEAN UROLOGY

Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

(2019) Frank-Jan H. Drost et al.   EUROPEAN UROLOGY

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

(2018) Veeru Kasivisvanathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study

(2018) Olivier Rouvière et al.   LANCET ONCOLOGY

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

(2017) Hashim U Ahmed et al.   LANCET

Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality

(2017) Jonas Hugosson et al.   Scandinavian Journal of Urology

Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial

(2016) Anna Grenabo Bergdahl et al.   EUROPEAN UROLOGY

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

(2015) Jonathan I. Epstein et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial

(2015) Rebecka Arnsrud Godtman et al.   EUROPEAN UROLOGY

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case–Control Study

(2015) Pär Stattin et al.   EUROPEAN UROLOGY

Overdiagnosis and Overtreatment of Prostate Cancer

(2014) Stacy Loeb et al.   EUROPEAN UROLOGY

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

(2014) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer

(2013) Monique J. Roobol et al.   EUROPEAN UROLOGY

Systematic Review of Complications of Prostate Biopsy

(2013) Stacy Loeb et al.   EUROPEAN UROLOGY

Prevalence of Prostate Cancer on Autopsy: Cross-Sectional Study on Unscreened Caucasian and Asian Men

(2013) Alexandre R. Zlotta et al.   JNCI-Journal of the National Cancer Institute

Defining the threshold for significant versus insignificant prostate cancer

(2013) Theo H. Van der Kwast et al.   Nature Reviews Urology

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

(2009) E A M Heijnsdijk et al.   BRITISH JOURNAL OF CANCER

Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era

(2009) Andrew J. Stephenson et al.   JOURNAL OF CLINICAL ONCOLOGY